Human D-Amino Acid Oxidase: Structure, Function, and Regulation
TLDR
The known properties of human DAAO suggest that its activity must be finely tuned to fulfill a main physiological function such as the control of D-serine levels in the brain as well as the role of post-translational modifications on its main biochemical properties at the cellular level.Abstract:
D-Amino acid oxidase (DAAO) is an FAD-containing flavoenzyme that catalyzes with absolute stereoselectivity the oxidative deamination of all natural D-amino acids, the only exception being the acidic ones. This flavoenzyme plays different roles during evolution and in different tissues in humans. Its three-dimensional structure is well conserved during evolution: minute changes are responsible for the functional differences between enzymes from microorganism sources and those from humans. In recent years several investigations focused on human DAAO, mainly because of its role in degrading the neuromodulator D-serine in the central nervous system. D-Serine is the main coagonist of N-methyl D-aspartate receptors, i.e., excitatory amino acid receptors critically involved in main brain functions and pathologic conditions. Human DAAO possesses a weak interaction with the FAD cofactor; thus, in vivo it should be largely present in the inactive, apoprotein form. Binding of active-site ligands and the substrate stabilizes flavin binding, thus pushing the acquisition of catalytic competence. Interestingly, the kinetic efficiency of the enzyme on D-serine is very low. Human DAAO interacts with various proteins, in this way modulating its activity, targeting, and cell stability. The known properties of human DAAO suggest that its activity must be finely tuned to fulfill a main physiological function such as the control of D-serine levels in the brain. At present, studies are focusing on the epigenetic modulation of human DAAO expression and the role of post-translational modifications on its main biochemical properties at the cellular level.read more
Citations
More filters
Journal ArticleDOI
Proteomic Analysis of Mouse Kidney Tissue Associates Peroxisomal Dysfunction with Early Diabetic Kidney Disease
TL;DR: In this paper , a comprehensive proteomic analysis was performed on the glomeruli and kidney cortex of diabetic mice with the subsequent validation of findings in human biopsies and omics datasets, aiming to better understand the underlying molecular biology of early DKD development and progression.
Journal ArticleDOI
The D-amino acid oxidase-carbon nanotubes: evaluation of cytotoxicity and biocompatibility of a potential anticancer nanosystem
TL;DR: In this paper , multi-walled carbon nanotubes (MWCNTs) were functionalized with polyethylene glycol (PEG) to reduce their tendency to aggregation and to improve their biocompatibility.
Journal ArticleDOI
Functional Characterization and Structural Modeling of a Novel Glycine Oxidase from Variovorax paradoxus Iso1
TL;DR: In this article , a putative FAD-binding glycine/d-amino acid oxidase was located immediately upstream of the N-d-AAase gene, and the protein was identified as a glycine oxidase and designated it VpGO.
Journal ArticleDOI
Structural Determinants of the Specific Activities of an L-Amino Acid Oxidase from Pseudoalteromonas luteoviolacea CPMOR-1 with Broad Substrate Specificity
Kyle J. Mamounis,Maria Luiza Caldas Nogueira,Daniela Priscila Marchi Salvador,Andres Andreo-Vidal,Antonio Sanchez-Amat,Victor L. Davidson +5 more
TL;DR: The Pseudoalteromonas luteoviolacea strain CPMOR-1 expresses a flavin adenine dinucleotide (FAD)-dependent L-amino acid oxidase (LAAO) with broad substrate specificity that was compared with structures of other FAD-dependent LAAOs that have different substrate specificities to provide insight into the structural determinants of the LAAO that dictate their different substrate preferences.
Journal ArticleDOI
D-Amino Acids and Cancer: Friends or Foes?
G.P. Murtas,Loredano Pollegioni +1 more
TL;DR: In this paper , the effects of the L-amino acid composition of foods and dietary modifications of this composition on the efficacy of cancer therapies have been widely investigated in relation to the growth and reproduction of cancerous cells.
References
More filters
Journal ArticleDOI
Central Sensitization: A Generator of Pain Hypersensitivity by Central Neural Plasticity
TL;DR: The major triggers that initiate and maintain central sensitization in healthy individuals in response to nociceptor input and in patients with inflammatory and neuropathic pain are reviewed, emphasizing the fundamental contribution and multiple mechanisms of synaptic plasticity caused by changes in the density, nature, and properties of ionotropic and metabotropic glutamate receptors.
Journal ArticleDOI
Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis
TL;DR: Hypofunction of the NMDA receptor, possibly on critical GABAergic inter-neurons, may contribute to the pathophysiology of schizophrenia.
Journal ArticleDOI
BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology.
TL;DR: The first update of BindingDB since 2007 is provided, focusing on new and unique features and highlighting directions of importance to the field as a whole.
Journal ArticleDOI
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
Elizabeth T. Cirulli,Brittany N. Lasseigne,Slavé Petrovski,Peter C. Sapp,Patrick A. Dion,Claire S. Leblond,Julien Couthouis,Yi-Fan Lu,Quanli Wang,Brian J. Krueger,Zhong-fa Ren,Jonathan E. M. Keebler,Yujun Han,Shawn Levy,Braden E. Boone,Jack R. Wimbish,Lindsay L. Waite,Angela Jones,John P. Carulli,Aaron G. Day-Williams,John F. Staropoli,Winnie Xin,Alessandra Chesi,Alya R. Raphael,Diane McKenna-Yasek,Janet Cady,J. M. B. Vianney de Jong,Kevin P. Kenna,Bradley N. Smith,Simon Topp,Jack W. Miller,Athina-Soragia Gkazi,Ammar Al-Chalabi,Leonard H. van den Berg,Jan H. Veldink,Vincenzo Silani,Nicola Ticozzi,Christopher Shaw,Robert H. Baloh,Stanley H. Appel,Ericka Simpson,Clotilde Lagier-Tourenne,Stefan M. Pulst,Summer Gibson,John Q. Trojanowski,Lauren Elman,Leo McCluskey,Murray Grossman,Neil A. Shneider,Wendy K. Chung,John Ravits,Jonathan D. Glass,Katherine B. Sims,Vivianna M. Van Deerlin,Tom Maniatis,Sebastian D. Hayes,Alban Ordureau,Sharan Swarup,John Landers,Frank Baas,Andrew S. Allen,Richard Bedlack,J. Wade Harper,Aaron D. Gitler,Guy A. Rouleau,Robert H. Brown,Matthew B. Harms,Gregory M. Cooper,Tim Harris,Richard M. Myers,David Goldstein +70 more
TL;DR: A moderate-scale sequencing study aimed at increasing the number of genes known to contribute to predisposition for ALS found several known ALS genes were found to be associated, and TBK1 (the gene encoding TANK-binding kinase 1) was identified as an ALS gene.
Journal ArticleDOI
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia.
Ilya Chumakov,Marta Blumenfeld,Oxana Guerassimenko,Laurent Cavarec,Marta Palicio,Hadi Abderrahim,Lydie Bougueleret,C Barry,Hiroaki Tanaka,Philippe La Rosa,Anne Puech,Nadia Tahri,Annick Cohen-Akenine,Sylvain Delabrosse,Sébastien Lissarrague,Françoise-Pascaline Picard,Karelle Maurice,Laurent Essioux,Philippe Millasseau,Pascale Grel,Virginie Debailleul,Anne-Marie Simon,Dominique Caterina,Isabelle Dufaure,Kattayoun Malekzadeh,Maria Belova,Jian-Jian Luan,Michel Bouillot,Jean-Luc Sambucy,Gwenael Primas,Martial Saumier,Nadia Boubkiri,Sandrine Martin-Saumier,Myriam Nasroune,Hélène Peixoto,A Delaye,Virginie Pinchot,Mariam Bastucci,Sophie Guillou,Magali Chevillon,Ricardo Sainz-Fuertes,Said Meguenni,Joan Aurich-Costa,Dorra Cherif,Anne Gimalac,Cornelia M. van Duijn,Denis Gauvreau,Gail Ouelette,Isabel Fortier,John Realson,Tatiana Sherbatich,Nadejda Riazanskaia,Evgeny I. Rogaev,Peter Raeymaekers,Jeroen Aerssens,Frank Konings,Walter Luyten,Fabio Macciardi,Pak C. Sham,Richard E. Straub,Daniel R. Weinberger,Nadine Cohen,Daniel Cohen +62 more
TL;DR: A map of 191 single-nucleotide polymorphism (SNPs) was built across a 5-Mb segment from chromosome 13q34 that has been genetically linked to schizophrenia, pointing to the involvement of this N-methyl-d-aspartate receptor regulation pathway in schizophrenia.